华东医药：2022年年度报告（英文版）.PDF

1、The 2022 Annual Report of Huadong Medicine Co.,Ltd.1 Huadong Medicine Co.,Ltd.2022 Annual Report April 2023The 2022 Annual Report of Huadong Medicine Co.,Ltd.2 A Letter to the Shareholders Distinguished shareholders,As the year ends,we usher in a new year with endless possibilities.The year of 2022

2、brought more challenges that forced the pharmaceutical industry to accelerate its transform,reshuffle and reshaping in response to the gloomy situation,numerous uncertainties,and downward pressure,which raises more challenges for pharmaceutical enterprises emergency response abilities and resilience

3、.For Huadong Medicine Co.,Ltd.(“We”or“the Company”),the year of 2022 witnessed our unremitting efforts and remarkable achievements,which is the first year for us to implement our seventh three-year planning,step forward to a new stage of innovative transformation and development,and pull off our vis

4、ions by 2030.By continuously strengthening the strategic guidance,focusing on the primary business of pharmaceuticals,taking active actions and seeking progress while maintaining stability,we have accelerated our businesses quarter by quarter and successfully achieved continuous growth against chang

5、es in the pharmaceutical industry under complicated internal and external environments in the new era.Over the past four years,we have kept improving our capacities,embracing more cooperation opportunities in an open manner,and endeavoring to seek sustained development,with the focus on four major b

6、usiness segments of pharmaceutical industry,pharmaceutical business,aesthetic medicine and industrial microbiology.Taking targeted steps from multiple aspects,we have made look-forwarding and international layout to adapt to cutting-edge innovative technology platforms and unsatisfied market demands